Overview

• An Argentine study presented at the International Headache Congress reports an average 11.4-year wait for a precise diagnosis, with patients seeing three clinicians before confirmation.
• In Argentina about 9.5% of the population—over 4 million people—live with migraine, while in Spain more than 1.5 million have the chronic form with over 15 headache days per month.
• Pediatric specialists estimate migraine affects 7–10% of children and adolescents, with school-related stress, sleep disruption and screen exposure among frequent triggers.
• Therapeutic options have expanded to include botulinum toxin, anti-CGRP monoclonal antibodies and gepants, yet high costs and uneven coverage leave many undertreated.
• Patient groups warn of lost productivity and quality-of-life impacts and caution that frequent unsupervised analgesic use can cause medication‑overuse headache, urging timely specialist care.